ChemSex and HIV: An Holistic Approach to HIV Treatment and Prevention for Crystal Meth Users
Vaty M. Poitevien, MD
Chief Medical Officer, Housing Works Community Healthcare
New York, NY
-and-
Pierre R. Arty, MD
Director of Psychiatry, Housing Works Community Healthcare
New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2019. All rights reserved.
Dr. Vaty Poitevien is the Chief Medical Officer of Housing Works, and previously served as Medical Director for Housing Works’ West 13th Street Health Center. Vaty joined Housing Works in 2005, following fellowship training at Columbia University’s College of Physicians and Surgeons and Harlem Hospital Center, focusing on infectious disease. She received her medical training at the State University of Haiti and completed her internal medicine residency at Brooklyn’s Woodhull Medical Center. She is board certified in both internal medicine and infectious disease. Dr. Poitevien has served lead investigator for HRSA’s Special Projects of National Significance HCV initiative.
Dr. Pierre Richard Arty was born in Cap-Haitien, Haiti, and was raised in the East Flatbush section of Brooklyn, N.Y. He completed undergraduate training at Columbia University, and then attended S.U.N.Y. Downstate Medical School in Brooklyn. After completing an Internal Medicine Residency at Kings County Hospital in Brooklyn, he pursued a Fellowship in Addictive Medicine, followed by a residency in Psychiatry at the same institution. He is Board Certified in Psychiatry and Addiction Medicine. He currently holds the position as Psychiatric Director for Housing Works, where he provides psychiatric supervision and direct psychopharmacological treatment for adults and those with chemical dependency.
At the completion of this educational session, learners will:
- Understand the importance of harm reduction strategies in the context of chemsex.
- Know how to identify and address psychiatric comorbidities in crystal meth users.
- Be aware of proposed treatment modalities for crystal meth use disorders.
- Appreciate new strategies of outreach and retention for HIV treatment and prevention in chemsex patients.
This CME activity has approved for
AMA PRA Category 1 Credit™ on February 12, 2019 and will terminate February 11, 2022.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Vaty M. Poitevien (Presenter) had no relevant financial relationships to disclose. Dr. Poitevien submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.
Dr. Pierre R. Arty (Presenter) had no relevant financial relationships to disclose. Dr. Arty submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
To obtain CME credit for this PRN program, please visit the
PRN Courses Page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
